{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:46:52Z","timestamp":1785548812732,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370779"],"award-info":[{"award-number":["82370779"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011790","name":"Xiangya Hospital, Central South University","doi-asserted-by":"publisher","award":["20210312"],"award-info":[{"award-number":["20210312"]}],"id":[{"id":"10.13039\/501100011790","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.mayocp.2024.11.024","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:08:58Z","timestamp":1744175338000},"page":"790-800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Benign Prostatic Hyperplasia Increases Long-term Chronic Kidney Disease Risk"],"prefix":"10.1016","volume":"100","author":[{"given":"Chenxi","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4583-2428","authenticated-orcid":false,"given":"Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.mayocp.2024.11.024_bib1","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1007\/s00345-023-04658-8","article-title":"Benign prostatic hyperplasia burden comparison between China and United States based on the Global Burden of Disease Study 2019","volume":"41","author":"Liu","year":"2023","journal-title":"World J Urol"},{"issue":"11","key":"10.1016\/j.mayocp.2024.11.024_bib2","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2666-7568(22)00213-6","article-title":"The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"3","year":"2022","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.024_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00345-021-03817-z","article-title":"Benign prostatic hyperplasia and cardiovascular risk: a prospective study among Chinese men","volume":"40","author":"Wang","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.mayocp.2024.11.024_bib4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ijbiomac.2022.11.162","article-title":"Decoding ceRNA regulatory network and autophagy-related genes in benign prostatic hyperplasia","volume":"225","author":"Zhou","year":"2023","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"10.1016\/j.mayocp.2024.11.024_bib5","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41419-022-05162-4","article-title":"METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m6A-YTHDF2\u2013dependent manner","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2024.11.024_bib6","first-page":"1965","article-title":"Prevalence of urinary symptoms and other urological conditions in Spanish men 50 years old or older","volume":"155","author":"Hunter","year":"1996","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.mayocp.2024.11.024_bib7","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1111\/j.1523-1755.2005.00344.x","article-title":"The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men","volume":"67","author":"Rule","year":"2005","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.mayocp.2024.11.024_bib8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000496289","article-title":"Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: a mini-review","volume":"65","author":"Madersbacher","year":"2019","journal-title":"Gerontology"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.024_bib9","first-page":"691","article-title":"Is benign prostatic hyperplasia a risk factor for chronic renal failure?","volume":"173","author":"Rule","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"3 suppl 3","key":"10.1016\/j.mayocp.2024.11.024_bib10","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1053\/j.ajkd.2008.07.048","article-title":"Conceptual model of CKD: applications and implications","volume":"53","author":"Levey","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.mayocp.2024.11.024_bib11","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3390\/ijerph16101726","article-title":"Finasteride-induced inhibition of 5\u03b1-reductase type 2 could lead to kidney damage-animal, experimental study","volume":"16","author":"Baig","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.024_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086215","article-title":"Drug-related problems in patients with benign prostatic hyperplasia: a cross sectional retrospective study","volume":"9","author":"Zaman Huri","year":"2014","journal-title":"PLoS One"},{"issue":"2pt 1","key":"10.1016\/j.mayocp.2024.11.024_bib13","first-page":"530","article-title":"(2003). Chapter 1: Diagnosis and treatment recommendations","volume":"170","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.mayocp.2024.11.024_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.eururo.2004.07.016","article-title":"EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines)","volume":"46","author":"Madersbacher","year":"2004","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.mayocp.2024.11.024_bib15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1464-410X.2003.04529.x","article-title":"A\u00a0review of guidelines on benign prostatic hyperplasia and lower urinary tract symptoms: are all guidelines the same?","volume":"92","author":"Irani","year":"2003","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.024_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.mayocp.2024.11.024_bib17","first-page":"806","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline Part I\u2014Initial Work-up and Medical Management","volume":"206","author":"Lerner","year":"2021","journal-title":"J\u00a0Urol"},{"issue":"D1","key":"10.1016\/j.mayocp.2024.11.024_bib18","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"10.1016\/j.mayocp.2024.11.024_bib19","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.biopsych.2020.11.019","article-title":"Socioeconomic deprivation index is associated with psychiatric disorders: an observational and genome-wide gene-by-environment interaction analysis in the UK Biobank cohort","volume":"89","author":"Ye","year":"2021","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.024_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010038","article-title":"Cross-sectional study of diet, physical activity, television viewing and sleep duration in 233,110 adults from the UK Biobank; the behavioural phenotype of cardiovascular disease and type 2 diabetes","volume":"6","author":"Cassidy","year":"2016","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.mayocp.2024.11.024_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/clinchem\/hvab278","article-title":"National Kidney Foundation Laboratory Engagement Working Group recommendations for implementing the CKD-EPI 2021 race-free equations for estimated glomerular filtration rate: practical guidance for clinical laboratories","volume":"68","author":"Miller","year":"2022","journal-title":"Clin Chem"},{"issue":"10","key":"10.1016\/j.mayocp.2024.11.024_bib22","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1464-410X.2009.08975.x","article-title":"Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"105","author":"Hong","year":"2010","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.mayocp.2024.11.024_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.ajkd.2010.03.021","article-title":"Use of a prostate symptom score to identify men at risk of future kidney failure: insights from the HUNT II study","volume":"56","author":"Hallan","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2024.11.024_bib24","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.urology.2013.07.049","article-title":"Relationship of estimated glomerular filtration rate with lower urinary tract symptoms\/benign prostatic hyperplasia measures in middle-aged men with moderate to severe lower urinary tract symptoms","volume":"82","author":"Lee","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.mayocp.2024.11.024_bib25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2147\/CIA.S392519","article-title":"Correlation between benign prostatic hyperplasia\/lower urinary tract symptoms and renal function in elderly men aged 80 years and older","volume":"18","author":"Wang","year":"2023","journal-title":"Clin Interv Aging"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.024_bib26","first-page":"205","article-title":"Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States","volume":"154","author":"Gee","year":"1995","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.mayocp.2024.11.024_bib27","doi-asserted-by":"crossref","first-page":"a1530","DOI":"10.1136\/bmj.a1530","article-title":"Early identification and management of chronic kidney disease: summary of NICE guidance","volume":"337","author":"Crowe","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.mayocp.2024.11.024_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2023.127596","article-title":"The human microbiome and benign prostatic hyperplasia: current understandings and clinical implications","volume":"281","author":"Li","year":"2024","journal-title":"Microbiol Res"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.024_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2024.2313410","article-title":"Microbiome analysis reveals the inducing effect of Pseudomonas on prostatic hyperplasia via activating NF-\u03baB signalling","volume":"15","author":"Li","year":"2024","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.mayocp.2024.11.024_bib30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.archger.2011.02.005","article-title":"Drug-related problems (DRPs) identified from geriatric medication safety review clinics","volume":"54","author":"Chan","year":"2012","journal-title":"Arch Gerontol Geriatr"},{"issue":"2","key":"10.1016\/j.mayocp.2024.11.024_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.amjopharm.2012.02.003","article-title":"Polypharmacy with common diseases in hospitalized elderly patients","volume":"10","author":"Mizokami","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"issue":"2","key":"10.1016\/j.mayocp.2024.11.024_bib32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/j.ajkd.2020.07.018","article-title":"Kidney, cardiac, and safety outcomes associated with \u03b1-blockers in patients with CKD: a population-based cohort study","volume":"77","author":"Hundemer","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.mayocp.2024.11.024_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242429","article-title":"Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: a nationwide population-based study in Taiwan","volume":"15","author":"Sung","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.mayocp.2024.11.024_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173301","article-title":"Management of benign prostate hyperplasia (BPH) by combinatorial approach using alpha-1-adrenergic antagonists and 5-alpha-reductase inhibitors","volume":"883","author":"Zitoun","year":"2020","journal-title":"Eur J Pharmacol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619624006505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619624006505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:40:17Z","timestamp":1762213217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619624006505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0025619624006505"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2024.11.024","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benign Prostatic Hyperplasia Increases Long-term Chronic Kidney Disease Risk","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2024.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}